$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-09-17 AccNo: 0001437749-18-017131 Size: 42 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接